Patents by Inventor Susan L. Strausberg

Susan L. Strausberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Calcium free subtilisin mutants
    Patent number: 5707848
    Abstract: Novel calcium free subtilisin mutants are taught, in particular a subtilisin which has been mutated to eliminate amino acids 75-83.
    Type: Grant
    Filed: November 27, 1995
    Date of Patent: January 13, 1998
    Assignee: University of Maryland
    Inventors: Philip N. Bryan, Patrick A. Alexander, Susan L. Strausberg
  • Eimeria antigenic composition which elicits antibodies against avian coccidiosis
    Patent number: 5597571
    Abstract: This invention relates to novel recombinant antigenic proteins of avian coccidiosis, and fragments thereof containing antigenic determinants, and to the genes that encode the antigenic peptides. This invention also relates to vaccines made using the novel antigenic proteins of avian coccidiosis and to methods of immunizing chickens against avian coccidia.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 28, 1997
    Assignee: British Technology Group USA Inc.
    Inventors: James W. Jacobson, Robert L. Strausberg, Susan D. Wilson, Sharon H. Pope, Susan L. Strausberg, Michael D. Ruff, Patricia C. Augustine, Harry D. Danforth
  • Subtilisin mutants lacking a primary calcium binding site
    Patent number: 5567601
    Abstract: Novel calcium free subtilisin mutants are taught, in particular subtilisins which have been mutated to eliminate amino acids 75-83 and which retain enzymatic activity and stability. Recombinant methods for producing same and recombinant DNA encoding for such subtilisin mutants are also provided.
    Type: Grant
    Filed: September 20, 1994
    Date of Patent: October 22, 1996
    Assignee: University of Maryland
    Inventors: Philip N. Bryan, Patrick A. Alexander, Susan L. Strausberg
  • Eimeria antigenic composition which elicits antibodies against avian coccidiosis
    Patent number: 5482709
    Abstract: This invention relates to novel recombinant antigenic proteins of avian coccidiosis, and fragments thereof containing antigenic determinants, and to the genes that encode the antigenic peptides. This invention also relates to vaccines made using the novel antigenic proteins of avian coccidiosis and to methods of immunizing chickens against avian coccidia.
    Type: Grant
    Filed: November 8, 1993
    Date of Patent: January 9, 1996
    Assignees: British Technology Group USA Inc., The United States of America as represented by the Dept. of Agriculture
    Inventors: James W. Jacobson, Robert L. Strausberg, Susan D. Wilson, Sharon H. Pope, Susan L. Strausberg, Michael D. Ruff, Patricia C. Augustine, Harry D. Danforth
  • Calcium free subtilisin mutants
    Patent number: 5470733
    Abstract: Novel calcium free subtilisin mutants are taught, in particular a subtilisin which has been mutated to eliminate amino acids 75-83.
    Type: Grant
    Filed: June 1, 1993
    Date of Patent: November 28, 1995
    Assignee: University of Maryland
    Inventors: Philip N. Bryan, Patrick A. Alexander, Susan L. Strausberg
  • 25 KD coccidial antigen of eimeria tenella
    Patent number: 5279960
    Abstract: A cloned gene or fragment thereof encodes antigenic proteins that bind with a monoclonal or polyvalent antibody that is directed against an antigenic protein of avian coccidia.
    Type: Grant
    Filed: May 5, 1992
    Date of Patent: January 18, 1994
    Assignees: Enzon Corp., U.S.A. Dept. of Agriculture
    Inventors: David M. Anderson, Russell J. McCandliss, Susan L. Strausberg, Robert L. Strausberg, Michael D. Ruff, Harry D. Danforth, Patricia C. Augustine
  • Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
    Patent number: 5273901
    Abstract: This invention relates to novel recombinant antigenic proteins of avian coccidiosis, and fragments thereof containing antigenic determinants, and to the genes that encode the antigenic peptides. This invention also relates to vaccines made using the novel antigenic proteins of avian coccidiosis and to methods of immunizing chickens against avian coccidia.
    Type: Grant
    Filed: September 12, 1990
    Date of Patent: December 28, 1993
    Assignees: Enzon Corp., U.S. Dept. of Agriculture
    Inventors: James W. Jacobson, Robert L. Strausberg, Susan D. Wilson, Sharon H. Pope, Susan L. Strausberg, Michael D. Ruff, Patricia C. Augustine, Harry D. Danforth
  • Production of bioadhesive precursor protein analogs by genetically engineered organisms
    Patent number: 5242808
    Abstract: Recombinant production of bioadhesive precursor protein analogs is disclosed. The bioadhesive precursor protein analogs can be hydroxylated and used as an adhesive in wet environments.
    Type: Grant
    Filed: January 23, 1991
    Date of Patent: September 7, 1993
    Assignee: Enzon, Inc.
    Inventors: Kathy J. Maugh, David M. Anderson, Susan L. Strausberg, Robert Strausberg, Tena Wei
  • Bioadhesive precursor protein expression vectors
    Patent number: 5202256
    Abstract: Vectors are provided that are capable of expressing, in microbial transformants, a protein having the native amino acid sequence of a bioadhesive precursor protein of a marine animal selected from the group consisting of mussels, barnacles, and oysters. The bioadhesive precursor protein can be expressed in transformants, recovered and converted to a bioadhesive protein by hydroxylation.
    Type: Grant
    Filed: August 16, 1991
    Date of Patent: April 13, 1993
    Assignee: Enzon Labs, Inc.
    Inventors: Kathy J. Maugh, David M. Anderson, Robert Strausberg, Susan L. Strausberg, Russ McCandliss, Tena Wei, David Filpula
  • Method of producing bioadhesive protein
    Patent number: 5202236
    Abstract: Vectors are provided that are capable of expressing, in microbial transformants, a protein having the native amino acid sequence of a bioadhesive precursor protein of a marine animal selected from the group consisting of mussels, barnacles, and oysters. The bioadhesive precursor protein can be expressed in transformants, recovered and converted to a bioadhesive protein by hydroxylation.
    Type: Grant
    Filed: May 25, 1990
    Date of Patent: April 13, 1993
    Assignee: Enzon Labs Inc.
    Inventors: Kathy J. Maugh, David M. Anderson, Robert Strausberg, Susan L. Strausberg
  • Bioadhesive coding sequences
    Patent number: 5049504
    Abstract: Vectors are provided that are capable of expressing, in microbial transformants, a protein having the native amino acid sequence of a bioadhesive precursor protein of a marine animal selected from the group consisting of mussels, barnacles, and oysters. The bioadhesive precursor protein can be expressed in transformants, recovered and converted to a bioadhesive protein by hydroxylation.
    Type: Grant
    Filed: May 30, 1990
    Date of Patent: September 17, 1991
    Assignee: Genex Corporation
    Inventors: Kathy J. Maugh, David M. Anderson, Robert Strausberg, Susan L. Strausberg, Russ McCandliss, Tena Wei, David Filpula
  • Composite yeast vectors
    Patent number: 5013652
    Abstract: A DNA sequence comprising:(a) a hybrid first yeast promoter comprising the functional segment of the DNA sequence encoding the upstream activation site of a gene selected from the group consisting of GAL1, GAL7 and GAL10, operably linked to the functional segment of the transcription initiation site of MF-.alpha.-1;(b) the functional segment of a signal sequence substantially comprising preferred yeast codons;(c) the functional segment of the DNA sequence comprising a Saccharomyces GAPDH transcription terminator;(d) the functional segment of the Saccharomyces 2.mu. circle replication origin; and(e) the functional segment of the yeast LEU2-d selectable marker. The DNA sequence may further comprise, inserted in phase between the signal sequence and transcription terminator, the functional segment of a DNA sequence encoding a heterologous target peptide.
    Type: Grant
    Filed: October 14, 1986
    Date of Patent: May 7, 1991
    Assignee: Genex Corporation
    Inventors: Robert L. Strausberg, Susan L. Strausberg